Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 2Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1Head & Neck 1

Conditions

Malignant Neoplasm in the Head and Neck 1

Interventions

Cyclophosphamide 129Cisplatin 119Radiotherapy 115pembrolizumab 111Carboplatin 97Paclitaxel 96Gemcitabine 96Magnetic Resonance Spectroscopy 80Nivolumab 76Bevacizumab 76Fluorouracil 74Dexamethasone 73Radiosurgery 66Docetaxel 59Rituximab 58Leucovorin 57Oxaliplatin 55Capecitabine 55Biopsy 53Doxorubicin 52fludarabine 51Drug Therapy 45durvalumab 44Cytarabine 44Etoposide 42fludarabine phosphate 40Pemetrexed 40Radiation 39atezolizumab 36Surveys and Questionnaires 36

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × iodixanol × Clear all
NCT05490381 2023-12-12

Preoperative Embolization of Hypervascular Head and Neck Tumors to Improve Surgical Outcomes

University of Washington

Phase 1 Withdrawn
Head & NeckOther neoplasm

Malignant Neoplasm in the Head and Neck

Data powered by HemOnc (CC BY 4.0) Colophon âš¡